PetMed Express, Inc.
PETS
$4.19
$0.020.48%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 247.01M | 259.34M | 270.77M | 281.06M | 276.97M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 247.01M | 259.34M | 270.77M | 281.06M | 276.97M |
Cost of Revenue | 178.64M | 188.00M | 196.68M | 202.42M | 199.11M |
Gross Profit | 68.37M | 71.34M | 74.09M | 78.65M | 77.85M |
SG&A Expenses | 60.28M | 65.69M | 68.36M | 79.92M | 75.38M |
Depreciation & Amortization | 6.86M | 7.04M | 7.10M | 7.06M | 6.16M |
Other Operating Expenses | -1.09M | -1.09M | -1.09M | -1.09M | 344.00K |
Total Operating Expenses | 244.69M | 259.65M | 271.05M | 288.31M | 280.99M |
Operating Income | 2.32M | -305.00K | -274.00K | -7.24M | -4.03M |
Income Before Tax | 1.92M | -488.00K | -133.00K | -6.27M | -2.34M |
Income Tax Expenses | 1.56M | 475.00K | 2.44M | 1.19M | 324.00K |
Earnings from Continuing Operations | 0.36 | -0.96 | -2.57 | -7.46 | -2.66 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 357.00K | -963.00K | -2.57M | -7.46M | -2.66M |
EBIT | 2.32M | -305.00K | -274.00K | -7.24M | -4.03M |
EBITDA | 8.18M | 5.74M | 5.83M | -1.19M | 2.13M |
EPS Basic | 0.02 | -0.05 | -0.13 | -0.37 | -0.13 |
Normalized Basic EPS | 0.11 | 0.04 | 0.04 | -0.16 | -0.06 |
EPS Diluted | 0.01 | -0.06 | -0.14 | -0.38 | -0.14 |
Normalized Diluted EPS | 0.10 | 0.03 | 0.03 | -0.16 | -0.06 |
Average Basic Shares Outstanding | 82.19M | 81.98M | 81.76M | 81.58M | 81.47M |
Average Diluted Shares Outstanding | 82.96M | 82.75M | 82.59M | 81.98M | 81.88M |
Dividend Per Share | 0.00 | 0.00 | 0.30 | 0.60 | 0.90 |
Payout Ratio | 54.34% | -21.60% | -250.16% | -166.63% | -696.47% |